Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bavarian Nordic A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
BVNRY
Over the counter
2836
www.bavarian-nordic.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bavarian Nordic A/S
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
- Feb 11th, 2026 11:43 pm
Bavarian Nordic – Completion of Share Buy-Back Program
- Feb 9th, 2026 1:21 am
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
- Feb 2nd, 2026 12:54 am
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
- Jan 23rd, 2026 12:00 am
Assessing Bavarian Nordic (CPSE:BAVA) Valuation After Recent Choppy Share Price Performance
- Jan 10th, 2026 4:11 pm
Is Bavarian Nordic (CPSE:BAVA) Pricing Reflect Its DCF Upside After Recent Vaccine Headlines
- Jan 10th, 2026 6:08 am
Bavarian Nordic Launches Planned Share Buy-Back Program
- Jan 7th, 2026 12:09 am
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
- Dec 18th, 2025 12:41 pm
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
- Dec 17th, 2025 12:30 am
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
- Dec 2nd, 2025 12:01 am
Should You Reassess Bavarian Nordic After Vaccine Pipeline and Share Price Drop?
- Nov 27th, 2025 8:11 pm
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
- Nov 26th, 2025 1:00 pm
Bavarian Nordic AS (BVNKF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
- Nov 14th, 2025 12:01 pm
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
- Nov 13th, 2025 11:37 pm
Bavarian Nordic Announces Changes to the Board of Directors
- Nov 13th, 2025 12:45 pm
Bavarian Nordic (CPSE:BAVA): Assessing Valuation After Recent Share Price Volatility
- Nov 11th, 2025 9:13 am
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
- Nov 10th, 2025 1:00 pm
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
- Nov 6th, 2025 7:03 am
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
- Nov 1st, 2025 3:34 am
Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira
- Oct 31st, 2025 7:07 am
Scroll